Aligos Therapeutics Inc (ALGS) — Long-term Investment Intensity
Aligos Therapeutics Inc (ALGS) has a Long-term Investment Intensity of 6.4% as of December 2021. Long-term investments of $15.11 Million represent 6.4% of total assets of $235.37 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check ALGS financial resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Aligos Therapeutics Inc Long-term Investment Intensity (2019–2021)
This chart shows how Aligos Therapeutics Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2019 to 2021. As of December 2021, the intensity stands at 6.4%, reflecting long-term investments of $15.11 Million against total assets of $235.37 Million USD. For the complete balance sheet picture, see Aligos Therapeutics Inc balance sheet assets.
Annual Long-term Investment Intensity for Aligos Therapeutics Inc (2019–2021)
The table below presents the year-by-year Long-term Investment Intensity for Aligos Therapeutics Inc from 2019 to 2021, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read ALGS total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 6.4% | $15.11 Million | $235.37 Million | ▼ -0.4 pp |
| 2019 | 6.8% | $10.02 Million | $146.52 Million | — |